← Open Payments lookup

KAELYN LAY: Open Payments

NPI 1962948075 · NORTH LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,429 in 75 payments from 18 companies in 2025. Trend: 2023 $824 · 2024 $1,826 · 2025 $1,429

Food & beverage: $1,429
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$319
ABBVIE INC.11$267
Lilly USA, LLC14$209
PFIZER INC.6$105
Astellas Pharma US Inc4$78
Amgen Inc.5$72
Novo Nordisk Inc4$67
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$64
Bayer Healthcare Pharmaceuticals Inc.4$56
Boehringer Ingelheim Pharmaceuticals, Inc.2$32

Products named: FARXIGA, QULIPTA, MOUNJARO, JARDIANCE, AIRSUPRA, Veozah, UBRELVY, OTEZLA.

Industry payments across AR — which companies pay providers there.